Sivan provides innovative digital therapeutic for the follow up of cancer patients. Thanks to its strong scientific evidence and clinical expertise, Sivan developed Moovcare®, the first application for early detection of relapses and complications in patients with lung cancer. Moovcare® is the first digital therapeutic officially reimbursed in France.